Human Gene Therapy Methods（人类基因治疗方法杂志）影响因子_期刊投稿发表

期刊简介

Human Gene Therapy is the premier, multidisciplinary journal covering all aspects of gene therapy. The Journal publishes in-depth coverage of DNA, RNA, and cell therapies by delivering the latest breakthroughs in research and technologies. Human Gene Therapy provides a central forum for scientific and clinical information, including ethical, legal, regulatory, social, and commercial issues, which enables the advancement and progress of therapeutic procedures leading to improved patient outcomes, and ultimately, to curing diseases.The Journal is divided into three parts. Human Gene Therapy, the flagship, is published 12 times per year. HGT Methods, a bimonthly journal, focuses on the applications of gene therapy to product testing and development. HGT Clinical Development, a quarterly journal, serves as a venue for publishing data relevant to the regulatory review and commercial development of cell and gene therapy products.

《人类基因治疗》是一本涵盖基因治疗各个方面的多学科期刊。该杂志通过提供最新的研究和技术突破，深入报道DNA、RNA和细胞疗法。人类基因治疗为科学和临床信息提供了一个中心论坛，包括伦理，法律的，监管，社会和商业问题，这使得治疗程序的进步和进展，导致改善患者的结果，并最终治愈疾病。该杂志分为三个部分。《人类基因治疗》是一本旗舰书，每年出版12期。《HGT方法》是一本双月刊，主要关注基因治疗在产品测试和开发中的应用。HGT Clinical Development是一份季刊，用于发布与细胞和基因治疗产品的监管审查和商业开发相关的数据。

《Human Gene Therapy Methods》期刊已被查看：次

分区信息